Skip to main content

Avera Medical oncologist presented SPRING trial results

Could a targeted three-drug combination help prolong the lives of patients who have a deadly form of advanced lung cancer? The SPRING trial sought to answer that question, and the final results show promise.

--- Online Subscribers: Please click here to log in to read this story and access

Not an Online Subscriber? Click here to subscribe.

Sign up for News Alerts

Subscribe to news updates